Skip to main content
logo
Liven Pharma Limited (PSX:LIVEN)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
34.80
-0.07 (-0.20%)
At close: Aug 20, 2026

Liven Pharma Financials Overview

Millions PKR. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
99.11127.27245.09---
Revenue Growth
-72.91%-48.07%----
Gross Profit
8.1415.8262.14---
Operating Income
-532.35-491.7141.77-15.22-17.51-18.19
Net Income
-701.22-584.4641.74-12.33-14.29-14.63
Earnings Per Share
-7.80-8.371043.60-1.02-1.18-1.21
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
178.87.8824.960.030.030.05
Total Debt
27.3734.67156.91237.62235.35233.11
Net Cash (Debt)
151.43-26.78-131.95-237.59-235.32-233.06
Net Cash Growth
------
Net Cash Per Share
1.68-0.38-3298.85-19.60-19.41-19.22

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
216.89-1.7213.8-2.27-2.26-6.79
Capital Expenditures
-32.16-22.84----
Free Cash Flow
184.72-24.5613.8-2.27-2.26-6.79
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
8.21%12.43%25.35%---
Operating Margin
-537.14%-386.34%17.04%---
Pretax Margin
-649.09%-386.72%17.03%---
Profit Margin
-707.52%-459.22%17.03%---
FCF Margin
186.39%-19.30%5.63%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PE Ratio
--2.65---
P/FCF Ratio
21.34-8.00---
PS Ratio
39.7747.470.45---